Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Roche begins phase III study of GDC-9545 with palbociclib in advanced breast cancer

Oct. 15, 2020

Arvinas announces new preclinical programs

Oct. 15, 2020

California Institute of Technology, 1200 Pharma and UC Oakland disclose PRMT5 inhibitors

Oct. 15, 2020

Derazantinib active in intrahepatic cholangiocarcinoma with FGFR2 mutations/amplifications

Oct. 14, 2020

First patient dosed in phase I study of NBTXR-3 in pancreatic cancer

Oct. 14, 2020

Shanghai Ringene Biopharma synthesizes new BRD and/or c-Myc inhibitors

Oct. 14, 2020

Sumitomo Dainippon Pharma Oncology presents new PKM2 activators

Oct. 14, 2020

Additional interim data presented for WP-1066 in adult glioblastoma

Oct. 14, 2020

Interim data from FIDES-02 study of derazantinib in advanced urothelial cancer

Oct. 14, 2020

Kinnate Biopharma discovers c-RAF inhibitors

Oct. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...